Browsing Tag
Pharma acquisition news
231 posts
PureTech Health acquires LYT-100 for lymphedema treatment
US biopharma company PureTech Health has acquired a clinical-stage product candidate called LYT-100, which will be developed as…
July 18, 2019
Boehringer Ingelheim acquires Swiss biotech company AMAL Therapeutics
Boehringer Ingelheim acquisition of AMAL Therapeutics : German pharma company Boehringer Ingelheim has acquired Swiss biotech company AMAL…
July 16, 2019
Merck to acquire US biopharma company Peloton Therapeutics in $2.2bn deal
Merck acquisition of Peloton : Pharma giant Merck is set to acquire US biopharma company Peloton Therapeutics in…
July 14, 2019
Thermo Fisher to acquire viral vector CDMO Brammer Bio for $1.7bn
Global life sciences company Thermo Fisher Scientific has agreed to acquire Massachusetts-based Brammer Bio from Ampersand Capital Partners…
April 7, 2019
Novartis completes $2.1bn acquisition of Endocyte to boost cancer treatment capabilities
Swiss pharmaceutical giant Novartis has officially closed its $2.1 billion acquisition of US-based biopharma company Endocyte, solidifying its…
December 23, 2018
Procter & Gamble completes game-changing acquisition of Merck’s consumer health unit
In a significant boost to its consumer health portfolio, Procter & Gamble (P&G) has concluded its €3.4 billion…
December 1, 2018
US biopharma company Endocyte to be acquired by Novartis for $2.1bn
Novartis acquisition of Endocyte : US biopharma company Endocyte has agreed to be acquired by Swiss pharma company…
October 21, 2018
Cambrex announces $425m acquisition of American CDMO Halo Pharma
Cambrex Corporation, a leading manufacturer of small molecules and generic Active Pharmaceutical Ingredients (APIs), has announced a strategic…
July 25, 2018
CVC Capital Partners leads consortium in €3.03bn acquisition of Recordati
In a landmark deal valued at approximately €3.03 billion, a consortium led by CVC Capital Partners through its…
July 1, 2018
Eli Lilly strengthens cancer portfolio with acquisition of Armo BioSciences and promising immunotherapy asset
Eli Lilly and Company (Lilly), a global leader in the pharmaceutical industry, has taken a significant step toward…
June 24, 2018